GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (NAS:IMRNW) » Definitions » EV-to-Revenue

IMRNW (Immuron) EV-to-Revenue : 0.00 (As of Jan. 19, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Immuron EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Immuron's enterprise value is $0.00 Mil. Immuron's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $3.27 Mil. Therefore, Immuron's EV-to-Revenue for today is 0.00.

The historical rank and industry rank for Immuron's EV-to-Revenue or its related term are showing as below:

IMRNW' s EV-to-Revenue Range Over the Past 10 Years
Min: -39.69   Med: 11.81   Max: 70.84
Current: 1.94

During the past 10 years, the highest EV-to-Revenue of Immuron was 70.84. The lowest was -39.69. And the median was 11.81.

IMRNW's EV-to-Revenue is ranked better than
78.39% of 1041 companies
in the Biotechnology industry
Industry Median: 7.11 vs IMRNW: 1.94

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-01-19), Immuron's stock price is $0.0732. Immuron's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00. Therefore, Immuron's PS Ratio for today is .


Immuron EV-to-Revenue Historical Data

The historical data trend for Immuron's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron EV-to-Revenue Chart

Immuron Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.14 77.62 -5.10 -0.95 1.75

Immuron Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.10 - -0.95 - 1.75

Competitive Comparison of Immuron's EV-to-Revenue

For the Biotechnology subindustry, Immuron's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuron's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuron's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Immuron's EV-to-Revenue falls into.



Immuron EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Immuron's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/3.268
=0.00

Immuron's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Immuron's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $3.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immuron  (NAS:IMRNW) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Immuron's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0732/
=

Immuron's share price for today is $0.0732.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immuron EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Immuron's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Immuron Business Description

Address
Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.